ArticleCancers2022

Impact of Delaying the Addition of Anti-EGFR in First Line of RAS Wild-Type Metastatic Colorectal Cancer: A Propensity-Weighted Pooled Data Analysis.

Lola-Jade Palmieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.